Moleculin Biotech Inc. Share (MBRX)

Moleculin Biotech Inc. is a biopharmaceutical company focused on the development of therapies for hard-to-treat cancers and viruses. The company's pipeline includes drug candidates targeting key metabolic processes believed to be critical for cancer cell survival and viral replication. Moleculin's research and development efforts are centered on identifying and advancing novel small molecule therapeutics with the potential to address significant unmet medical needs. The company is committed to bringing innovative solutions to patients facing challenging oncological and viral conditions. By targeting fundamental biological mechanisms, Moleculin aims to create more effective and less toxic treatment options. Its strategic focus encompasses both preclinical and clinical development stages, with a goal of ultimately commercializing its therapeutic candidates.